Balyasny Asset Management L.P.

Position in PHAT — Phathom Pharmaceuticals, Inc.

CIK 1218710 Chicago, IL

Position in PHAT

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$1,058,794

-$2,376,746 QoQ

Shares Held

95,301

-54.0% QoQ

Ownership

0.119%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2022

8 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

Balyasny Asset Management L.P. holds $2,162,876,033 across 177 Biotechnology names. PHAT ranks #131 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TERN	Terns Pharmaceuticals, Inc.	2,779,445	$146,532,340
2	ERAS	Erasca, Inc.	5,143,985	$83,229,677
3	TNGX	Tango Therapeutics, Inc.	3,826,659	$80,053,706
4	APLS	Apellis Pharmaceuticals, Inc.	1,917,501	$77,141,065
5	BMRN	Biomarin Pharmaceutical Inc	1,362,752	$76,981,860
6	CYTK	Cytokinetics Inc	992,545	$65,418,640
7	DAWN	Day One Biopharmaceuticals, Inc.	2,625,235	$56,285,038
8	FOLD	AMICUS THERAPEUTICS, INC.	3,827,513	$55,345,837

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,058,794	95,301	-54.0%	Shares	Sole	2026-05-15
2025-12-31	$3,435,540	207,085	-29.8%	Shares	Sole	2026-02-17
2025-09-30	$3,474,044	295,161	+2139.1%	Shares	Sole	2025-11-14
2025-06-30	$126,415	13,182	-71.2%	Shares	Sole	2025-08-14
2025-03-31	$287,360	45,831	-30.2%	Shares	Sole	2025-05-15
2024-09-30	$1,187,114	65,659	+337.6%	Shares	Sole	2024-11-14
2024-06-30	$154,561	15,006	-19.0%	Shares	Sole	2024-08-14
2022-09-30	$205,334	18,532	—	Shares	Sole	2022-11-15
No filing history on record for this holder in this stock.